Home > Boards > US Listed > Medical - Drugs > ISTA Pharmaceuticals Inc. (ISTA)

ISTA says FDA to review eye drug by

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
surf1944 Member Profile
 
Followed By 436
Posts 25,114
Boards Moderated 5
Alias Born 09/11/06
160x600 placeholder
surf1944   Saturday, 03/27/10 12:51:32 PM
Re: None
Post # of 69 
ISTA says FDA to review eye drug by Oct. 16
ISTA Pharmaceuticals says FDA to review once-daily eye inflammation treatment by Oct. 16

On Monday March 8, 2010, 5:54 pm EST
IRVINE, Calif. (AP) -- ISTA Pharmaceuticals Inc. said Monday the Food and Drug Administration will make a regulatory decision on the once-daily eye inflammation treatment XiDay by Oct. 16.

The drug is a once-per-day version of Xibrom, a drug that is already on the market but is intended to be used twice a day.

XiDay, like Xibrom, is aimed at treating eye inflammation following cataract surgery.

ISTA said the FDA is still considering the company's request for a shorter, six-month, priority review.

ISTA reported Xibrom net sales of $81.1 million for the year ended December 31, 2009.

Shares of ISTA rose 6 cents to $3.89 in after-hours trading after rising 10 cents, or 2.7 percent, to close at $3.83 during the regular trading session.




surf's up......crikey



Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist